National and Kapodistrian University of Athens
Μελέτη της έκφρασης των υποδοχέων της οικογένειας του επιδερμικού αυξητικού παράγοντα (epidermal growth factor, EGF), (EGFR ή HER-1, HER-2, HER-3, HER-4) στον καρκίνο του παχέος εντέρου: προγνωστική αξία και συσχέτιση με παθολογοανατομικές παραμέτρους
Abstract
dc:descriptionBackground: In this study we sought to determine the pattern and the prognostic significance of EGFR, HER/2neu, HER-3 and HER-4 protein expression in colorectal adenocarcinoma. Methods: Immunohistochemistry was performed in paraffin embedded specimens of 106 colorectal carcinomas for the assessment of EGFR, HER-2, HER-3 and HER-4 protein expression. The results were correlated with traditional clinicopathological parameters and patient outcome. Results: Membranous expression of EGFR was found in 50 cases (47,16%) and cytoplasmic expression in 32 cases (30,18%). Membranous overexpression of Her2 was identified in 6 cases (5,66%) while cytoplasmic expression was found in 18 cases (16,98%). HER-3 staining displayed membranous and cytoplasmic expression pattern in 18 (17%) and 30 samples (28,3%), respectively. HER-4 membranous and cytoplasmic expression was found in 20 (18,9%) and 32 samples (30,2%), respectively. The correlation with other clinicopathological parameters demonstrated a statistically significant expression of membranous EGFR in the older age group (p=0,009) and a statistically significant expression of membranous Her-2 in patients with negative lymph nodes (p=0,014). None of the other parameters or patient prognosis was associated with EGFR or HER-2 membranous expression. Cytoplasmic expression was not related with any of above studied parameters. Specimens regarded as positive for HER-3 cytoplasmic expression were associated with moderate tumor grade (p=0,032) and older median age (p=0,010). Specimens regarded as positive for HER-4 membranous protein expression were associated with involved lymph nodes (p=0,0003). Similar results were obtained when considering Her-3 and Her-4 protein expression irrespective of their cellular localization. There was no correlation between the expression of HER-3 and HER-4 and patients outcome. Conclusion: Conventional IHC was unable to reveal any association between EGFR expression and outcome predicted by the biological role of EGFR in tumor behavior. Her-2/neu is not a pivotal pathway in colorectal cancer progression as it seems to be expressed at early stages of colorectal cancer. HER-4 membranous protein expression was found to predict for lymph nodes positivity in this cohort of patients with colorectal cancer.HER-4 expression status may identify tumors with aggressive biological behavior and increased metastatic potential.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kountourakis, Panteleimon
- Κουντουράκης, Παντελεήμων
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/25244